Literature DB >> 29679338

C-Reactive Protein on Postoperative Day 1: a Predictor of Early Intra-abdominal Infections After Bariatric Surgery.

Dino Kröll1, Dominik Nakhostin2, Guido Stirnimann2, Suna Erdem2, Tobias Haltmeier2, Philipp Christoph Nett2, Yves Michael Borbély2.   

Abstract

BACKGROUND: Early intra-abdominal infections (IAI) compromise short-term outcomes in bariatric surgery. The timely detection of IAI is challenging but essential to prevent major sequelae of such complications. C-reactive protein (CRP) is a reliable marker for detecting IAI after colorectal surgery. In bariatric surgery, data on CRP as a marker for IAI are limited, particularly for postoperative day one (POD1).
OBJECTIVE: The objective of this study was to assess CRP on POD1 as a predictor for early IAI (within 7 days following surgery) in patients after laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (LRYGB).
METHODS: Patients with bariatric surgery between 08/2010 and 06/2017 were included. The predictive capacity of CRP for early IAI was determined using a receiver operating characteristics (ROC) analysis.
RESULTS: In 523 patients (68.5% female, LSG = 358, LRYGB = 165), 16 (3%) early IAI were observed. ROC analysis revealed a significant predictive capacity of POD1 CRP for early IAI, with a sensitivity and a specificity of 81.2 and 94.3%, respectively, at a CRP cut-off value of 70 mg/L. In patients with confirmed early IAI, 81.3% had a CRP level ≥ 70 mg/L (LSG 85.7%, LRYGB 77.8%). The negative predictive value for a CRP level < 70 mg/L was 99.4% overall and was 100 and 98% for LSG and LRYGB, respectively.
CONCLUSION: In patients with a CRP level < 70 mg/L on POD1, early IAI can be excluded with high accuracy in bariatric patients. Thus, early postoperative CRP may be used to assess the risk of early IAI in enhanced recovery programs.

Entities:  

Keywords:  C-reactive protein; Intra-abdominal infections; Organ space surgical site infections; Postoperative complications; ROC curve analysis; Roux-en-Y gastric bypass; Sleeve gastrectomy

Mesh:

Substances:

Year:  2018        PMID: 29679338     DOI: 10.1007/s11695-018-3240-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  28 in total

1.  [Nationwide surveillance of nosocomial infections in Switzerland--methods and results of the Swiss Nosocomial Infection Prevalence Studies (SNIP) in 1999 and 2002].

Authors:  H Sax
Journal:  Ther Umsch       Date:  2004-03

Review 2.  Complications of bariatric surgery.

Authors:  Edward H Livingston
Journal:  Surg Clin North Am       Date:  2005-08       Impact factor: 2.741

3.  Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy.

Authors:  Michel Gagner; Mervyn Deitel; Ann L Erickson; Ross D Crosby
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

4.  Anastomotic leakage after colorectal surgery: can it be detected earlier and more easily?

Authors:  A Dupré; K Slim
Journal:  J Visc Surg       Date:  2012-10-23       Impact factor: 2.043

5.  Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients.

Authors:  Rene Warschkow; Ulrich Beutner; Thomas Steffen; Sascha A Müller; Bruno M Schmied; Ulrich Güller; Ignazio Tarantino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

6.  C-Reactive Protein and Procalcitonin as Early Markers of Septic Complications after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients Within an Enhanced Recovery After Surgery Program.

Authors:  José Luis Muñoz; Jaime Ruiz-Tovar; Elena Miranda; Diana Lorena Berrio; Pedro Moya; Manuel Gutiérrez; Raquel Flores; Carlos Picó; Ana Pérez
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

7.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Am J Infect Control       Date:  1999-04       Impact factor: 2.918

8.  The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration.

Authors:  M H Wener; P R Daum; G M McQuillan
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

9.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

10.  Inflammatory response measured by body temperature, C-reactive protein and white blood cell count 1, 3, and 5 days after laparotomic or laparoscopic gastric bypass surgery.

Authors:  Attila Csendes; Ana Maria Burgos; Daniel Roizblatt; Claudio Garay; Pablo Bezama
Journal:  Obes Surg       Date:  2008-10-02       Impact factor: 4.129

View more
  4 in total

1.  Diagnostic Value of C-Reactive Protein Levels in Postoperative Infectious Complications After Bariatric Surgery: a Systematic Review and Meta-Analysis.

Authors:  Yung Lee; Tyler McKechnie; Aristithes G Doumouras; Chovav Handler; Cagla Eskicioglu; Scott Gmora; Mehran Anvari; Dennis Hong
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

2.  Does C-reactive Protein Have a Predictive Role in the Early Diagnosis of Postoperative Complications After Bariatric Surgery? Systematic Review and Bayesian Meta-analysis.

Authors:  Davide Bona; Giancarlo Micheletto; Gianluca Bonitta; Valerio Panizzo; Marta Cavalli; Emanuele Rausa; Silvia Cirri; Alberto Aiolfi
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

3.  Associations between Pre-Bariatric High-Sensitivity C-Reactive Protein and Post-Surgery Outcomes.

Authors:  Tannaz Jamialahmadi; Mohsen Nematy; Simona Bo; Valentina Ponzo; Ali Jangjoo; Ladan Goshayeshi; Aida Tasbandi; Nikita G Nikiforov; Amirhossein Sahebkar
Journal:  Diagnostics (Basel)       Date:  2021-04-18

4.  Prediction of early C-reactive protein levels after non-cardiac surgery under general anesthesia.

Authors:  Shiroh Nakamoto; Munetaka Hirose
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.